D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$757M |
| 2 |
Alibaba
BABA
|
+$544M |
| 3 |
Booking.com
BKNG
|
+$475M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$377M |
| 5 |
Caterpillar
CAT
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.07B |
| 2 |
Amazon
AMZN
|
+$486M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$443M |
| 4 |
Salesforce
CRM
|
+$363M |
| 5 |
Qualcomm
QCOM
|
+$352M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.27% |
| 2 | Consumer Discretionary | 9.91% |
| 3 | Healthcare | 7.11% |
| 4 | Financials | 6.94% |
| 5 | Communication Services | 6.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4151
Southside Bancshares
SBSI
$966M
| $333K | ﹤0.01% |
+8,691
| New | +$320K |
|
4152
Atlanta Braves Holdings Series A
BATRA
$3.53B
| $331K | ﹤0.01% |
12,313
-9,395
| -43% | -$251K |
|
4153
Minerva Neurosciences
NERV
$196M
| $331K | ﹤0.01% |
23,757
-15,950
| -40% | -$240K |
|
4154
Omega Flex
OFLX
$305M
| $331K | ﹤0.01% |
2,319
| – | – |
|
|
ZENV
4155
DELISTED
Zenvia
ZENV
| $331K | ﹤0.01% |
+24,061
| New | +$345K |
|
4156
CEVA Inc
CEVA
$980M
| $330K | ﹤0.01% |
7,740
-3,836
| -33% | -$174K |
|
|
BFX
4157
DELISTED
BowFlex Inc.
BFX
| $327K | ﹤0.01% |
+35,171
| New | +$452K |
|
4158
CDW
CDW
$17.6B
| $326K | ﹤0.01% |
1,793
-5,730
| -76% | -$1.08M |
|
4159
Insteel Industries
IIIN
$624M
| $326K | ﹤0.01% |
8,571
-14,165
| -62% | -$522K |
|
|
SVM
4160
Silvercorp Metals
SVM
$2.16B
| $326K | ﹤0.01% |
+85,500
| New | +$387K |
|
|
AVDL
4161
DELISTED
Avadel Pharmaceuticals
AVDL
| $324K | ﹤0.01% |
33,041
+19,405
| +142% | +$153K |
|
4162
Jakks Pacific
JAKK
$297M
| $324K | ﹤0.01% |
+27,249
| New | +$344K |
|
4163
PUT
Nu Skin
NUS
$250M
| $324K | ﹤0.01% |
+8,000
| New | +$405K |
|
4164
PUT
Polaris
PII
$4.25B
| $323K | ﹤0.01% |
+2,700
| New | +$343K |
|
|
FSR
4165
CALL
DELISTED
Fisker Inc.
FSR
| $322K | ﹤0.01% |
+22,000
| New | +$331K |
|
|
GSQB
4166
DELISTED
G Squared Ascend II Inc.
GSQB
| $322K | ﹤0.01% |
+32,940
| New | +$321K |
|
4167
Pinnacle Financial Partners Inc
PNFP
$15.6B
| $321K | ﹤0.01% |
3,414
-4,556
| -57% | -$419K |
|
4168
Duluth Holdings
DLTH
$162M
| $320K | ﹤0.01% |
+23,493
| New | +$375K |
|
|
HES
4169
PUT
DELISTED
Hess
HES
| $320K | ﹤0.01% |
4,100
-1,000
| -20% | -$73.7K |
|
4170
Alpha Metallurgical Resources
AMR
$1.85B
| $319K | ﹤0.01% |
+6,400
| New | +$230K |
|
|
DADA
4171
DELISTED
Dada Nexus
DADA
| $319K | ﹤0.01% |
+15,917
| New | +$360K |
|
4172
PUT
8x8 Inc
EGHT
$262M
| $318K | ﹤0.01% |
13,600
| – | – |
|
4173
PUT
Repligen
RGEN
$7.39B
| $318K | ﹤0.01% |
+1,100
| New | +$282K |
|
4174
Root
ROOT
$944M
| $317K | ﹤0.01% |
3,344
-138
| -4% | -$17.1K |
|
4175
CALL
Criteo
CRTO
$1.05B
| $315K | ﹤0.01% |
8,600
-8,800
| -51% | -$339K |
|
Similar funds
D.E. Shaw & Co's Q3 2021 Portfolio in Review
As of Q3 2021, D.E. Shaw & Co held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
D.E. Shaw & Co withdrew a net $8.92B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Sea Limited worth $206M.
- D.E. Shaw & Co's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
- D.E. Shaw & Co added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
- D.E. Shaw & Co's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
- D.E. Shaw & Co fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
- D.E. Shaw & Co's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
- D.E. Shaw & Co opened 915 new positions and closed 695 in Q3 2021.
- D.E. Shaw & Co's portfolio value fell 4.4% quarter-over-quarter to $111B.
Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.